Skip to content
MTRIInMed Pharmaceuticals Inc.

MTRI holders

Who holds InMed Pharmaceuticals Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
17
Shares held
6.7M
Value held
$8.3M
Opened
5
Closed
8

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Eventide Asset Management, LLC4.4MNew$5.5M0.1%Nov 13, 2026
Vivo Capital, LLC824.9K+3.3%$1.1M0.1%Nov 13, 2026
Seven Fleet Capital Management LP1.1MNew$1M0.2%Nov 16, 2026
Ikarian Capital, LLC137.6K−43.8%$187.2K0.1%Nov 16, 2026
Venrock Adviser, LLC133.4K+308.1%$181.4K0.1%Nov 16, 2026
Jane Street Group, LLC52.9K+22.9%$72K0%Nov 12, 2026
Citadel Advisors LLC43K+64.7%$58.4K0%Nov 16, 2026
Boothbay Fund Management, LLC39.9K−46.2%$54.3K0.1%Nov 16, 2026
Seven Grand Managers, LLC25K±0%$34K0.1%Nov 16, 2026
XTX Topco Ltd19KNew$25.9K0.1%Nov 16, 2026
Crestwood Advisors Group, LLC14.9K±0%$20.3K0.1%Oct 27, 2026
Two Sigma Investments, LP11.9KNew$16.2K0%Nov 16, 2026
Private Wealth Management Group, LLC5K±0%$6.8K0.1%Oct 19, 2026
UBS Group AG3.2KNew$4.3K0%Nov 10, 2026
SBI Securities Co., Ltd.300±0%$4080%Oct 22, 2026
Federation des caisses Desjardins du Quebec2±0%$20%Nov 16, 2026
Banque Cantonale Vaudoise6±0%$00%Nov 12, 2026